Showing results (2321-2330 of 2,572) with videos related to

Sort By:
Pageof 258
Plos One|January 27, 2011
Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastomaKenneth L Pitter, Craig J Galbán, Stefanie Galbán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Phase I dose-escalation study of the pan-HER inhibitor, PF299804, in patients with advanced malignant solid tumorsPasi A Jänne, David S Boss, D Ross Camidge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2018
Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer PatientsBritt I Drögemöller, Beth Brooks, Carol Critchley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2023
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I TrialEtan Orgel, Kristin R Knight, Yueh-Yun Chi, et al.
International Journal of Oncology|March 6, 2017
Gene expression profiling in bladder cancer identifies potential therapeutic targetsSyed A Hussain, Daniel H Palmer, Wing-Kin Syn, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 14, 1998
1H MRS in acute traumatic brain injuryB D Ross, T Ernst, R Kreis, et al.
Mbio|January 5, 2024
Intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosisCourtney E Price, Rebecca A Valls, Alexis R Ramsey, et al.
The Journal of Head Trauma Rehabilitation|March 19, 2026
Factors Associated With Return-to-Learn Duration After Concussion in US Service Academy Cadets and MidshipmenJeremy D Ross, Michael J Aderman, Megan H Roach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2022
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung CancerRoy S Herbst, Margarita Majem, Fabrice Barlesi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor responseBradford A Moffat, Thomas L Chenevert, Theodore S Lawrence, et al.
Pageof 258